CYH

Business Context and Reporting Period

Company: Community Health Systems, Inc. (CHS)
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2002
Overview: CHS is the largest non-urban provider of general hospital healthcare services in the U.S. by facility count and second largest by revenue. As of year-end 2002, the company owned, leased, or operated 63 hospitals across 22 states with 6,310 licensed beds. In over 85% of its markets, CHS is the sole provider of general hospital services.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Net operating revenues increased 29.9% to $2.2 billion, driven by acquisitions (contributing $343.3 million) and organic growth at same hospitals (9.7%).
• Profitability: Net income more than doubled to $100 million. This was significantly aided by the adoption of SFAS No. 142, which eliminated goodwill amortization (saving ~$28.8 million in expenses), and a $31.6 million reduction in interest expense due to refinancing and lower rates.
• EBITDA Margins: Consolidated EBITDA margins decreased from 18.2% to 16.4% due to the integration of newly acquired hospitals which initially have lower margins. However, on a same-hospital basis, EBITDA margins improved from 18.2% to 18.4%.
• Acquisitions: In 2002, CHS acquired six hospitals for approximately $173 million. Post-year-end (Jan 1, 2003), the company acquired seven additional hospitals for $148 million.
• Debt Refinancing: In July 2002, the company refinanced its credit facility into a $1.2 billion senior secured facility, extending maturities and reducing interest costs.

Guidance, Outlook, and Risks

• Acquisition Strategy: Management intends to acquire two to four hospitals annually in non-urban markets. The company anticipates purchasing two to three hospitals in 2003.
• Capital Expenditures: Expected capital expenditures for 2003 are estimated between $135 million and $140 million, including $35–$38 million for replacement hospital construction.
• Regulatory Risks: The company faces significant exposure to changes in Medicare and Medicaid reimbursement rates. Approximately 44% of revenue is derived from these government programs. Legislative changes or payment reductions could adversely affect results.
• Compliance: CHS is subject to a Corporate Compliance Agreement with the Office of Inspector General (OIG) regarding historical coding issues, running through June 2003. Violations could result in penalties or exclusion from federal programs.
• Legal Proceedings: The company is involved in a False Claims Act qui tam action (Bledsoe v. CHS) which was dismissed at the district court level but is currently on appeal. Additionally, there are class action lawsuits regarding a nurse infected with HIV at a Texas facility, which management believes are without merit.

Investor Verification Checklist

• Goodwill Accounting: Verify the impact of SFAS No. 142 on reported earnings, as the elimination of goodwill amortization significantly boosted 2002 net income compared to prior years.
• Acquisition Integration: Monitor the timeline for margin improvement at the six hospitals acquired in 2002 and the seven acquired in early 2003, as these currently drag down consolidated EBITDA margins.
• Debt Covenants: Review the restrictive covenants in the new $1.2 billion credit facility, specifically regarding leverage ratios and the prohibition on dividends without amendment.
• Reimbursement Trends: Track legislative developments regarding Medicare and Medicaid payment rates, given that nearly half of the company's revenue is government-sourced.
• Compliance Status: Confirm the company's adherence to the OIG Corporate Compliance Agreement terms through its expiration in June 2003 to avoid potential penalties.